Vanguard Global Advisers’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Hold
996
– – ﹤0.01% 3479
2026
Q2
$13.1K Hold
996
– – ﹤0.01% 3427
2026
Q1
$26.2K Buy
+996
New +$125K ﹤0.01% 3239

Other funds holding GOSS

Vanguard Global Advisers's GOSS Position: Q3 2026 in Review

Vanguard Global Advisers held its Gossamer Bio (GOSS) position steady in Q3 2026 at 996 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

Vanguard Global Advisers first reported a position in GOSS in Q1 2026 and has held it in 3 quarters since. The position peaked at $26.2K in Q1 2026. 75 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Vanguard Global Advisers held 996 shares of Gossamer Bio worth $11.8K as of Q3 2026.
  • Vanguard Global Advisers left its Gossamer Bio share count unchanged in Q3 2026.
  • Gossamer Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3479 holding.
  • Vanguard Global Advisers first reported a position in Gossamer Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Gossamer Bio position peaked at $26.2K in Q1 2026.
  • 75 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.